![Piotr Dubno](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Piotr Dubno
Profile
Mr. Piotr Dubno is Chairman-Supervisory Board at Nepentes SA.
Former positions of Piotr Dubno
Companies | Position | End |
---|---|---|
PKO TFI SA
![]() PKO TFI SA Investment ManagersFinance PKO TFI SA is the fund management subsidiary of Powszechna Kasa Oszczednosci Bank Polski SA (WSE: PKO) in Poland. Headquartered in Warsaw, the firm was established by PKO Bank Polski and Swiss financial group Credit Suisse in 1997 to provide a variety of funds and investment schemes, available via their distribution network across Poland for individual and institutional clients. | Director/Board Member | 01/01/2012 |
Nepentes SA
![]() Nepentes SA Pharmaceuticals: MajorHealth Technology Nepentes SA manufactures and distributes pharmaceutical products. The company focuses on creating formulas and solutions in dermatology, paediatrics and cough and cold. The company manufactures products under the brands, include Iwostin, Emolium, Elixine, Propodia and Propolki. The company's production plants are located in ?ód? and Chociw. The company operates under five segments, wholesale of pharmaceuticals, wholesale of cosmetics, production of cosmetics, production of diet supplements and advertising and promotional service. It was founded in 1991 and is headquartered in Warszawa, Poland. | Chairman | - |
Experiences
Positions held
Linked companies
Private companies | 2 |
---|---|
PKO TFI SA
![]() PKO TFI SA Investment ManagersFinance PKO TFI SA is the fund management subsidiary of Powszechna Kasa Oszczednosci Bank Polski SA (WSE: PKO) in Poland. Headquartered in Warsaw, the firm was established by PKO Bank Polski and Swiss financial group Credit Suisse in 1997 to provide a variety of funds and investment schemes, available via their distribution network across Poland for individual and institutional clients. | Finance |
Nepentes SA
![]() Nepentes SA Pharmaceuticals: MajorHealth Technology Nepentes SA manufactures and distributes pharmaceutical products. The company focuses on creating formulas and solutions in dermatology, paediatrics and cough and cold. The company manufactures products under the brands, include Iwostin, Emolium, Elixine, Propodia and Propolki. The company's production plants are located in ?ód? and Chociw. The company operates under five segments, wholesale of pharmaceuticals, wholesale of cosmetics, production of cosmetics, production of diet supplements and advertising and promotional service. It was founded in 1991 and is headquartered in Warszawa, Poland. | Health Technology |
- Stock Market
- Insiders
- Piotr Dubno